Unbiased AI-powered news
The Heart and Stroke Foundation warned that extreme heat in Central Canada places added strain on the heart and increases dehydration risk for people with cardiovascular conditions. Those taking certain heart and blood-pressure medications were advised to monitor hydration closely.
winnipegfreepress.comThe Heart and Stroke Foundation stated that a current heat wave in Central Canada can be especially dangerous for people with cardiovascular conditions. The foundation said extreme heat forces the heart to work harder to move blood to the skin's surface while the body sweats to cool itself. It added that dehydration becomes a significant risk during such periods.
People taking heart or high-blood-pressure medications, including diuretics, ACE inhibitors, and calcium channel blockers, need to be extra vigilant about fluid intake, the foundation said. m. m. Residents without air conditioning were encouraged to use libraries, malls, or community cooling centers.
The foundation described heat stroke as a medical emergency in which the body loses its ability to regulate temperature. Symptoms can include hot, dry skin, confusion, dizziness, a rapid heart rate, vomiting, diarrhea, and headache. If someone shows signs of heat stroke, call 911, move the person to a cooler area, and apply cool water, fanning, or ice packs while waiting for help, the foundation advised.
The organization noted that heat stroke is distinct from a stroke, which occurs when blood flow to part of the brain is interrupted.
These outlets didn't split into competing frames — coverage was uniform.
A 26-year-old Colombian national was fatally shot in Biddeford on Monday. The incident prompted federal officials to suspend most vehicle stops nationwide after two recent deaths.
Retired pilot Chesley Sullenberger said on July 14, 2026, that he has early-stage Alzheimer’s disease. He described initial symptoms and expressed resolve to face the condition with his family.
Japan TimesThe University of Oxford has started an early-stage clinical trial of a vaccine targeting the Bundibugyo strain of Ebola. The trial will enroll 50 healthy adults to test safety and immune response.